This peptide is still going through clinical investigation, and researchers are possible even now refining the ideal dosage for their scientific studies resulting from its novelty. Retatrutide is the newest weight-loss medication that functions being a triple agonist at GLP-one, GIP, and glucagon receptors. The medication is indicated for weight